AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Naloxone Hydrochloride
7 registrations across 3 African markets— 7 active
Markets with Naloxone Hydrochloride
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Naloxone HCl Fresenius 0,4 mg/1 ml Solution for Injection | 🇿🇲Zambia | FRESENIUS KABI MANUFACTURING SA (PTY) LIMITED | active | Jun 2030 |
| Naloxone 0.042 injection Solution for Injection | 🇿🇲Zambia | FRESENIUS KABI MANUFACTURING SA (PTY) LIMITED | active | Jun 2030 |
| NALOTAS Solution for Injection/Infusion Solution For Injection | 🇰🇪Kenya | Tasa Pharma Limited | active | Sept 2028 |
| NALOXONE HCl NEONATAL 0,02 mg/1 ml FRESENIUS | 🇿🇦South Africa | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | Jan 1900 |
| NALOXONE HCL 0,4 mg/1 ml FRESENIUS | 🇿🇦South Africa | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | Jan 1900 |
| PHARMA-Q NALOXONE INJECTION 0,4 mg/ml | 🇿🇦South Africa | Pharma-Q Holdings (Pty) Ltd | active | Jan 1900 |
| SABAX NALOXONE 0,02 mg/ml | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
Naloxone Hydrochloride in Africa — Regulatory Overview
Naloxone Hydrochloride is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zambia, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.